ADAM17 and COVID-19: Hypothetically, the largest possible number of overlapping samples accounted for 48% of total subjects in the GWAS of ADAM17, 0.8% of subjects in the GWAS of hospitalized COVID-19, 0.7% of subjects for the GWAS of SARS-CoV-2 reported infections and 0% of subjects for GWAS of critical COVID-19.